GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » ROE % Adjusted to Book Value

Consun Pharmaceutical Group (HKSE:01681) ROE % Adjusted to Book Value : 18.83% (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group ROE % Adjusted to Book Value?

Consun Pharmaceutical Group's ROE % for the quarter that ended in Jun. 2024 was 21.65%. Consun Pharmaceutical Group's PB Ratio for the quarter that ended in Jun. 2024 was 1.15. Consun Pharmaceutical Group's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 18.83%.

Consun Pharmaceutical Group ROE % Adjusted to Book Value Historical Data

The historical data trend for Consun Pharmaceutical Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consun Pharmaceutical Group ROE % Adjusted to Book Value Chart

Consun Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.10 25.40 21.91 24.42 24.16

Consun Pharmaceutical Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.78 27.49 17.97 26.56 18.83

Competitive Comparison of Consun Pharmaceutical Group's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Consun Pharmaceutical Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Consun Pharmaceutical Group's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Consun Pharmaceutical Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Consun Pharmaceutical Group's ROE % Adjusted to Book Value falls into.


Consun Pharmaceutical Group ROE % Adjusted to Book Value Calculation

Consun Pharmaceutical Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=22.95% / 0.95
=24.16%

Consun Pharmaceutical Group's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=21.65% / 1.15
=18.83%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Consun Pharmaceutical Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Consun Pharmaceutical Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
HKSE:06896 HKSE:02877 HKSE:02348 HKSE:01061 HKSE:02552 HKSE:06600 HKSE:00460 HKSE:02633 HKSE:03737 HKSE:01652 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
C1P:Germany
Address
71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN
Website
https://www.chinaconsun.com
Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.
Executives
Double Grace International Limited 2101 Beneficial owner
Li Qian 2101 Beneficial owner
An Yubao 2101 Beneficial owner
Central Success Developments Limited 2101 Beneficial owner
Aali Resources Limited 2201 Interest of corporation controlled by you
Bos Trustee Limited 2301 Trustee
Zhang Lihua 2202 Interest of your spouse
An Meng 2101 Beneficial owner
Bos Trustee Limited As Trustee 2201 Interest of corporation controlled by you

Consun Pharmaceutical Group Headlines

No Headlines